NASDAQ: OKYOOkyo Pharma Ltd Stock Ownership - Who owns Okyo Pharma?
Insider buying vs selling
Have Okyo Pharma Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when OKYO insiders and whales buy or sell their stock.
OKYO Shareholders
What type of owners hold Okyo Pharma Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gabriele M. Cerrone | 1,627.62% | 552,359,118 | $673.88M | Insider |
| Barclays PLC | 2.83% | 961,000 | $1.17M | Institution |
| Citadel Advisors LLC | 0.06% | 20,729 | $25.29k | Institution |
| John P. Brancaccio | 0.05% | 16,670 | $20.34k | Insider |
| Renaissance Technologies LLC | 0.05% | 16,500 | $20.13k | Institution |
| Cerity Partners LLC | 0.04% | 12,812 | $15.63k | Institution |
| Gary S. Jacob | 0.04% | 12,500 | $15.25k | Insider |
| Geode Capital Management LLC | 0.04% | 12,090 | $14.75k | Institution |
| Ubs Group Ag | 0.01% | 2,998 | $3.66k | Institution |
| Continuum Advisory LLC | 0.00% | 50 | $61.00 | Institution |
OKYO vs Biotech Stocks
Okyo Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.